[Usefulness of the Sensititre YeastOne® panel to detect Candida species resistant to antifungal drugs].

We evaluated the interlaboratory agreement, the essential agreement, and the categorical agreement between the Sensititre YeastOne panel and the reference methods M27 4 Edition of the Clinical and Laboratory Standards Institute (CLSI), and the EDef 7.3.1 of the European Committee on Antifungal Susceptibility Testing (EUCAST).

[Identification of Candida yeasts: Conventional methods and MALDI-TOF MS].

Background: Invasive fungal infections are increasing, and Candida yeasts are the main cause. Species other than Candida albicans are becoming more frequent, and some of them may have variable patterns of susceptibility to antifungal agents, making it important to identify them correctly. Conventional identification methods used by most laboratories may present with drawbacks.

Comparison of the identification results of Candida species obtained by BD Phoenix™ and Maldi-TOF (Bruker Microflex LT Biotyper 3.1).

In patients with invasive fungal infections, the accurate and rapid identification of the genus Candida is of utmost importance since antimycotic sensitivity is closely related to the species. The aim of the present study was to compare the identification results of species of the genus Candida obtained by BD Phoenix™ (Becton Dickinson [BD]) and Maldi-TOF MS (Bruker Microflex LT Biotyper 3.1).

[Fungemia in hospitals of the city of Buenos Aires, Argentina].

Background: The incidence of fungi like pathogens in hospitals varies by regions.

Objectives: Our goal was not only to record the incidence and etiology of fungaemia, but also the change during the 4 years analysed, to determine the time of detection in automated blood culture and by lysis-centrifugation, and finally to assess the gender, age and underlying disease of the patients with fungaemia.

Methods: An observational multicentre study of fungaemia was conducted in hospitals in the Mycology Network of Buenos Aires.